Modern Diagnostic IPO GMP: Price Band, Dates, Lot Size & Complete Analysis (2025–26)

The Modern Diagnostic IPO GMP is gaining attention among SME IPO investors as the company prepares to enter the primary market at the end of December 2025. With rising demand for healthcare and diagnostic services in India, investors are closely tracking the grey market premium (GMP) to assess possible listing gains and overall market sentiment.

In this article, we cover everything you need to know about the Modern Diagnostic IPO GMP, including issue details, price band, subscription dates, lot size, and key investment insights.

Modern Diagnostic IPO Overview

The Modern Diagnostic IPO is a book-built issue with a total issue size of ₹36.89 crore. The issue is entirely a fresh issue of 0.41 crore equity shares, which means the funds raised will go directly to the company to support its growth plans.

• Issue Size: ₹36.89 crore

  
  

• Fresh Issue: 0.41 crore shares

• Issue Type: Book Build Issue

• Exchange: BSE SME

Modern Diagnostic IPO Dates

Here are the important dates investors should keep in mind:

• IPO Open Date: December 31, 2025

• IPO Close Date: January 2, 2026

• Allotment Date: January 5, 2026 (Expected)

• Listing Date: January 7, 2026 (Tentative)

• Stock Exchange: BSE SME

Modern Diagnostic IPO Price Band

The Modern Diagnostic IPO price band has been fixed at:

• Lower Band: ₹85 per share

• Upper Band: ₹90 per share

Investors bidding at the upper price band will need to consider the higher capital requirement, especially for retail and HNI categories.

Modern Diagnostic IPO Lot Size & Investment Details

Retail Investors

• Lot Size: 1,600 shares

• Minimum Shares (Retail): 3,200 shares

• Minimum Investment: ₹2,88,000 (at ₹90 per share)

HNI / NII Investors

• Minimum Lots: 3 lots

• Total Shares: 4,800 shares

• Minimum Investment: ₹4,32,000 (at upper price band)

Due to the SME structure, the minimum investment amount is higher than mainboard IPOs, making this issue more suitable for informed and high-risk-tolerant investors.

Modern Diagnostic IPO GMP Today

The Modern Diagnostic IPO GMP reflects unofficial trading activity in the grey market before listing. GMP helps investors understand market demand and expected listing performance.

• A positive GMP usually indicates strong investor interest and potential listing gains

• A low or zero GMP suggests cautious sentiment

Investors should note that IPO GMP is unofficial and volatile. It can change daily based on market conditions and subscription trends.

Should You Track Modern Diagnostic IPO GMP?

Tracking the Modern Diagnostic IPO GMP today can help investors:

• Gauge short-term listing expectations

• Understand market sentiment before allotment

• Compare risk vs reward for SME IPO investments

However, GMP should not be the sole basis for investment decisions. Investors should also consider business fundamentals, issue pricing, and long-term growth potential.

Key Things to Know Before Investing

• SME IPOs are high risk–high reward

• Lower liquidity compared to mainboard stocks

• GMP is not guaranteed profit

• Suitable for investors with higher risk appetite

Final Thoughts on Modern Diagnostic IPO GMP

The Modern Diagnostic IPO GMP will remain a key indicator for investors tracking this issue ahead of its BSE SME listing. With a ₹36.89 crore fresh issue, fixed price band, and defined timelines, the IPO offers an opportunity for investors looking to participate in the healthcare diagnostics segment through the SME platform.

For latest updates on Modern Diagnostic IPO GMP, allotment status, and listing performance, keep tracking Finowings IPO GMP updates.

#moderndiagnosticipogmp
#moderniagnosticipo
#finowings